NCT07779603

Brief Summary

The purpose of this study is to evaluate the relationship between lipedema and osteoporosis and to examine factors that may be associated with osteoporosis in individuals with lipedema.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 18, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

August 20, 2026

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 21, 2026

Completed
26 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 16, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 16, 2026

Completed
Last Updated

August 21, 2026

Status Verified

August 1, 2026

Enrollment Period

27 days

First QC Date

August 18, 2026

Last Update Submit

August 18, 2026

Conditions

LipedemaOsteoporosis

Outcome Measures

Primary Outcomes (1)

  • DXA

    Dual-energy X-ray absorptiometry (DEXA) measurements for the lumbar and hip regions for the lumbar and hip regions

    1 day

Study Arms (2)

Group1

postmenopausal patients diagnosed with lipedema

Other: DXA

Group2

postmenopausal patients without lipedema

Other: DXA

Interventions

DXAOTHER

Dual-energy X-ray absorptiometry (DXA) measurements will be recorded for the lumbar and hip regions

Group1Group2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

postmenopausal patients with or without a diagnosis of lipedema

You may qualify if:

  • being literate
  • voluntarily agreeing to participate in the study
  • being a postmenopausal woman
  • having a diagnosis of lipedema

You may not qualify if:

  • the presence of other types of edema in which a component other than lipedema predominates (e.g., lymphedema, venous edema, edema associated with heart or kidney failure, etc.)
  • chronic liver disease,
  • body mass index (BMI) of over 50.0 (this condition reflects severe obesity, which has a significant impact on health beyond lipedema alone)
  • the presence of rheumatological diseases that may lead to secondary osteoporosis
  • a history of cancer, endocrine disorders, neurological disorders, certain gastrointestinal disorders
  • use of medications related to osteoporosis
  • being under 18 years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

LipedemaOsteoporosis

Condition Hierarchy (Ancestors)

Connective Tissue DiseasesSkin and Connective Tissue DiseasesBone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 18, 2026

First Posted

August 21, 2026

Study Start

August 20, 2026

Primary Completion

September 16, 2026

Study Completion

September 16, 2026

Last Updated

August 21, 2026

Record last verified: 2026-08